SCHEMBL6170638

SCHEMBL6170638

O=C(O)C=Cc1cc(Cl)ccc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 1/20 0.60
HSP90AA1 P07900 1/20 0.60
HSP90AB1 P08238 1/20 0.60
KEAP1 Q14145 1/20 0.52
NFE2L2 Q16236 1/20 0.52
CCR2 P41597 2/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
KCNA5 P22460 1/20 0.48
ACLY P53396 1/20 0.48
CPT1A P50416 1/20 0.47
CPT1B Q92523 1/20 0.47
ITGB2 P05107 1/20 0.45
ICAM1 P05362 1/20 0.45
ITGAL P20701 1/20 0.45
METAP2 P50579 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170634 1.00 ERBB2 (0.60) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2
SCHEMBL6172083 0.90 ERBB2 (0.57) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2
SCHEMBL6172085 0.90 ERBB2 (0.57) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2
SCHEMBL6170544 0.88 ERBB2 (0.55) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2
SCHEMBL6170538 0.88 ERBB2 (0.55) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2
SCHEMBL7488011 0.85 KEAP1 (0.53) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2
SCHEMBL7488003 0.85 KEAP1 (0.53) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2
SCHEMBL8120283 0.83 SNCA (0.56) KEAP1NFE2L2HTT
SCHEMBL8120286 0.83 SNCA (0.56) KEAP1NFE2L2HTT
SCHEMBL8112835 0.82 MEN1 (0.48) ERBB2HSP90AA1HSP90AB1KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1065206-B1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER (US) 2002-10-09 EP disclosed
EP-1065206-A1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER INC. (US) 2001-01-03 EP disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed